Vista Pharmaceuticals Quarterly Results for Trading Insights
VISTAPH • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-5 Cr
QMarch 2025
Vista Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹11 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
- Net Profit of ₹-5 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
- EBITDA of ₹-4 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of -40.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹-0.79 in March 2025 (+0.0% vs March 2025)
Vista Pharmaceuticals Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 9 | 11 | 11 | 1 | 1 | -18.2% | - |
| Net Profit (₹ Cr) | -7 | -5 | -5 | -6 | -1 | - | - |
| EBITDA (₹ Cr) | -7 | -4 | -3 | -4 | -1 | - | - |
| EPS (₹) | -1.50 | -0.79 | -1.03 | -1.54 | -0.24 | - | - |
| Operating Margin (%) | -99.0% | -40.0% | -32.0% | -443.0% | -321.0% | - | - |
Vista Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize Vista Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Vista Pharmaceuticals share price
chart using Tickjournal. All values in ₹.
Related Pages for Vista Pharmaceuticals
Additional stock information and data for VISTAPH
Revenue Trend (₹ Cr)
March 2023
1
March 2024
11
March 2025
11
2026
9
Net Profit Trend (₹ Cr)
March 2023
-6
March 2024
-5
March 2025
-5
2026
-7
Operating Margin Trend (%)
March 2023
-443.0%
March 2024
-32.0%
March 2025
-40.0%
2026
-99.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Vista Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4092.2 | 3,219 | 591 | +11.3% | - | 18.4% | 233.3 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores